MGLL and neurodegenerative disease: Thus, it has been proposed that MAGL is a therapeutic target for neurodegenerative diseases, including Alzheimer’s disease, amyotrophic lateral sclerosis, multiple sclerosis, Parkinson’s disease, and traumatic brain injury [23–25, 29–33].